Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas

被引:11
作者
Attis, Maria Gallego [1 ]
Burchette, James L. [1 ]
Selim, M. Angelica [1 ]
Pham, Tram [1 ]
Soler, Alejandro Peratta [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
关键词
desmoplastic melanoma; spindle cell melanoma; N-cadherin; immunohistochemistry; metastases;
D O I
10.1016/j.humpath.2006.02.013
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Desmoplastic melanoma is a variant of spindle cell melanoma considered at low risk for distant metastases when compared with other forms of melanoma. The emphasis in the differential diagnosis of desmoplastic melanomas has been placed mostly in distinguishing it from scars and other benign spindle cell proliferations. In contrast, recognizing a subset of desmoplastic melanomas with higher metastatic potential has proven more difficult. We studied the expression of N-cadherin in 21 desmoplastic melanomas. The expression of N-cadherin was examined by immunohistochemistry using archive material and a mouse anti-N-cadherin monoclonal antibody previously shown to react in routinely processed paraffin-embedded tissues. Of 21 cases. N-cadherin was strongly positive in 10. only weakly or focally positive in 3. and negative in 8. Seven of 21 patients had distant metastases, and N-cadherin was strongly positive in 6 of those 7 cases. In contrast, only 1 of 11 patients within the group of N-cadherin-negative or weakly positive tumors had distant metastases. Our results show that strong N-cadherin expression in desmoplastic melanoma correlates with distant metastases and potentially more aggressive behavior. In contrast. desmoplastic melanomas with low metastatic potential are mostly negative OF Only focally positive for N-cadherin. The data Suggest that N-cadherin may be a useful marker in recognizing a subset of desmoplastic melanoma with higher metastatic potential. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:899 / 905
页数:7
相关论文
共 38 条
[1]   Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma [J].
Andersen, K ;
Nesland, JM ;
Holm, R ;
Florenes, VA ;
Fodstad, O ;
Mælandsmo, GM .
MODERN PATHOLOGY, 2004, 17 (08) :990-997
[2]   DESMOPLASTIC MALIGNANT-MELANOMA - A CLINICOPATHOLOGICAL STUDY OF 25 CASES [J].
ANSTEY, A ;
MCKEE, P ;
JONES, EW .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (04) :359-371
[3]  
BAER SC, 1995, CANCER, V76, P2242, DOI 10.1002/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO
[4]  
2-I
[5]  
BARNHILL RL, 2004, PATHOLOGY MELANOCYTI, P289
[6]   DESMOPLASTIC MELANOMA [J].
BRUIJN, JA ;
MIHM, MC ;
BARNHILL, RL .
HISTOPATHOLOGY, 1992, 20 (03) :197-205
[7]   Cutaneous desmoplastic melanoma [J].
Busam, KJ .
ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (02) :92-102
[8]   Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling [J].
Busam, KJ ;
Zhao, H ;
Coit, DG ;
Kucukgol, D ;
Jungbluth, AA ;
Nobrega, J ;
Viale, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (02) :412-419
[9]   Cutaneous desmop astic melanoma - Reappraisal of morphologic heterogeneity and prognostic factors [J].
Busam, KJ ;
Mujumdar, U ;
Hummer, AJ ;
Nobrega, J ;
Hawkins, WG ;
Coit, DG ;
Brady, MS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) :1518-1525
[10]  
CONLEY J, 1971, CANCER, V28, P914, DOI 10.1002/1097-0142(1971)28:4<914::AID-CNCR2820280415>3.0.CO